Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
N Engl J Med
.
2021 Apr 22;384(16):1577.
doi: 10.1056/NEJMc2036242.
Epub 2021 Feb 17.
Author
Jean-Noel Vergnes
1
Affiliation
1
Paul Sabatier University, Toulouse, France jn.vergnes@gmail.com.
PMID:
33596349
DOI:
10.1056/NEJMc2036242
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19*
Humans
RNA, Messenger
SARS-CoV-2
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine